Alterola Biotech Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Alterola Biotech Inc Announces Management Change-Form 8-K
Alterola Biotech Inc reported in its Form 8-K that on February 13, 2012, the Board of Directors appointed Rene Lauritsen to the Board of Directors. In addition, the Board appointed Rene Lauritsen as President, Chief Executive Officer (CEO), Chief Financial Officer (CFO) and Secretary. Following these appointments, the board accepted the resignation of Tobias Hedstrom as former officer and Director.
Latest Developments for Alterola Biotech Inc
Latest Key Developments in Pharmaceuticals
- Share this
- Digg this